Cite
IL-15 armoring enhances the antitumor efficacy of claudin 18.2-targeting CAR-T cells in syngeneic mouse tumor models.
MLA
Hongtai Shi, et al. “IL-15 Armoring Enhances the Antitumor Efficacy of Claudin 18.2-Targeting CAR-T Cells in Syngeneic Mouse Tumor Models.” Frontiers in Immunology, Aug. 2023, pp. 1–14. EBSCOhost, https://doi.org/10.3389/fimmu.2023.1165404.
APA
Hongtai Shi, Andi Li, Zhenyu Dai, Jiao Xue, Qi Zhao, Jiyuan Tian, Dandan Song, Hao Wang, Jianan Chen, Xiaokang Zhang, Kaisong Zhou, Huafeng Wei, & Songbing Qin. (2023). IL-15 armoring enhances the antitumor efficacy of claudin 18.2-targeting CAR-T cells in syngeneic mouse tumor models. Frontiers in Immunology, 1–14. https://doi.org/10.3389/fimmu.2023.1165404
Chicago
Hongtai Shi, Andi Li, Zhenyu Dai, Jiao Xue, Qi Zhao, Jiyuan Tian, Dandan Song, et al. 2023. “IL-15 Armoring Enhances the Antitumor Efficacy of Claudin 18.2-Targeting CAR-T Cells in Syngeneic Mouse Tumor Models.” Frontiers in Immunology, August, 1–14. doi:10.3389/fimmu.2023.1165404.